Background
Background The relative efficacy of
The relative efficacy of different psychological treatments for different psychological treatments for chronic post-traumatic stress disorder chronic post-traumatic stress disorder (PTSD) is unclear. (PTSD) is unclear.
Aims Aims To determine the efficacy of
To determine the efficacy of specific psychological treatments for specific psychological treatments for chronic PTSD. chronic PTSD.
Method Method In a systematic review of
In a systematic review of randomised controlled trials, eligible randomised controlled trials, eligible studies were assessed against studies were assessed against methodological quality criteria and data methodological quality criteria and data were extracted and analysed. were extracted and analysed.
Results
Results Thirty-eight randomised Thirty-eight randomised controlled trials were included in the controlled trials were included in the meta-analysis.Trauma-focused cognitivemeta-analysis.Trauma-focused cognitiveb ehavioural therapy (TFCBT), eye behavioural therapy (TFCBT), eye movement desensitisation and movement desensitisation and reprocessing (EMDR), stress management reprocessing (EMDR), stress management and group cognitive^behavioural therapy and group cognitive^behavioural therapy improved PTSD symptoms more than improved PTSD symptoms more than waiting-list or usual care.There was waiting-list or usual care.There was inconclusive evidence regarding other inconclusive evidence regarding other therapies.There was no evidence of a therapies.There was no evidence of a difference in efficacy betweenTFCBTand difference in efficacy betweenTFCBTand EMDR butthere was some evidence that EMDR butthere was some evidence that TFCBTand EMDR were superior to stress TFCBTand EMDR were superior to stress management and other therapies, and management and other therapies, and that stress management was superior to that stress management was superior to other therapies. other therapies.
Conclusions Conclusions The first-line
The first-line psychological treatment for PTSD should psychological treatment for PTSD should be trauma-focused (TFCBTor EMDR). be trauma-focused (TFCBTor EMDR).
Declaration of interest Declaration of interest None.
None.
Chronic post-traumatic stress disorder Chronic post-traumatic stress disorder (PTSD) is a common disorder that people (PTSD) is a common disorder that people may develop after exceptionally threatening may develop after exceptionally threatening and distressing events. Psychological treat-and distressing events. Psychological treatments from various theoretical perspectives ments from various theoretical perspectives have been found to be effective for chronic have been found to be effective for chronic PTSD in previous reviews (Van Etten & PTSD in previous reviews (Van Etten & Taylor, 1988; Bradley Taylor, 1988; Bradley et al et al, 2005) . , 2005). Some of Some of the earlier reviews had to rely on un-the earlier reviews had to rely on uncontrolled trials as well as controlled ones, controlled trials as well as controlled ones, and on uncontrolled effect sizes. There are and on uncontrolled effect sizes. There are now sufficient numbers of randomised con-now sufficient numbers of randomised controlled trials of psychological treatments of trolled trials of psychological treatments of chronic PTSD to allow a meta-analysis of ef-chronic PTSD to allow a meta-analysis of effect sizes in such trials. We present a compre-fect sizes in such trials. We present a comprehensive systematic review and meta-analysis hensive systematic review and meta-analysis of randomised controlled trials assessing the of randomised controlled trials assessing the efficacy of psychological treatments in redu-efficacy of psychological treatments in reducing symptoms of chronic PTSD, and com-cing symptoms of chronic PTSD, and comparing the efficacy of different types of paring the efficacy of different types of psychological treatment in reducing symp-psychological treatment in reducing symptoms of this disorder. toms of this disorder.
METHOD METHOD
This review and meta-analysis derive from This review and meta-analysis derive from work undertaken in the preparation of work undertaken in the preparation of PTSD treatment guidelines for the National PTSD treatment guidelines for the National Institute for Health and Clinical Excellence Institute for Health and Clinical Excellence (NICE) in the UK (National Collaborating (NICE) in the UK (National Collaborating Centre for Mental Health, 2005) . Further Centre for Mental Health, 2005) . Further details of the protocol are published within details of the protocol are published within the full guideline. the full guideline.
A systematic bibliographic search was A systematic bibliographic search was undertaken to find randomised controlled undertaken to find randomised controlled trials of psychological treatments for PTSD trials of psychological treatments for PTSD from databases (EMBASE, Medline, from databases (EMBASE, Medline, PsycINFO and CINAHL) and the Cochrane PsycINFO and CINAHL) and the Cochrane Library, with each database being searched Library, with each database being searched from inception to August 2004. Additional from inception to August 2004. Additional papers were found by hand-searching the papers were found by hand-searching the references of retrieved articles, previous references of retrieved articles, previous systematic reviews and meta-analyses of psy-systematic reviews and meta-analyses of psychological treatments for PTSD. The search chological treatments for PTSD. The search was restricted to papers with English-was restricted to papers with Englishlanguage abstracts. In addition, data from language abstracts. In addition, data from unpublished studies or papers in press were unpublished studies or papers in press were sought by contacting experts within the field. sought by contacting experts within the field.
Selection Selection
Studies were only considered if PTSD Studies were only considered if PTSD symptoms were the main target of treat-symptoms were the main target of treatment, all participants had had PTSD symp-ment, all participants had had PTSD symptoms for at least 3 months following a toms for at least 3 months following a traumatic event, at least 70% of partici-traumatic event, at least 70% of participants had a diagnosis of PTSD, and PTSD pants had a diagnosis of PTSD, and PTSD symptoms were measured using a recog-symptoms were measured using a recognised scale. To be included studies had to nised scale. To be included studies had to be of randomised controlled design, with be of randomised controlled design, with adult ( adult (4 416 years old) participants; the 16 years old) participants; the studies had to report at least pre-treatment studies had to report at least pre-treatment and post-treatment measures, and retain at and post-treatment measures, and retain at least 50% of the original sample at the least 50% of the original sample at the post-treatment assessment. There was no post-treatment assessment. There was no restriction regarding type of traumatic restriction regarding type of traumatic event. The minimum duration of symptoms event. The minimum duration of symptoms was 1 month. Early intervention trials that was 1 month. Early intervention trials that only included participants with recent onset only included participants with recent onset of PTSD were not included and are consid-of PTSD were not included and are considered in a separate review (further details ered in a separate review (further details available from the author upon request). available from the author upon request). The searching and selection were done by The searching and selection were done by a team of systematic reviewers led by a team of systematic reviewers led by R.M. Any disagreements with regard to in-R.M. Any disagreements with regard to inclusion or exclusion of a study were re-clusion or exclusion of a study were resolved by discussion with the other authors. solved by discussion with the other authors.
Validity assessment Validity assessment
All published and unpublished papers were All published and unpublished papers were assessed against the following quality assessed against the following quality criteria: random sequence generation, criteria: random sequence generation, concealment of allocation, masked assess-concealment of allocation, masked assessment of outcomes, number of withdrawals, ment of outcomes, number of withdrawals, tolerability, adequate reporting of data and tolerability, adequate reporting of data and intention-to-treat analysis. intention-to-treat analysis.
Data abstraction Data abstraction
Study details including the nature of the Study details including the nature of the traumatic events, participants' characteris-traumatic events, participants' characteristics and type of intervention were entered tics and type of intervention were entered into a Microsoft Access database (version into a Microsoft Access database (version 2000), the quality criteria were applied 2000), the quality criteria were applied and outcome data for included studies were and outcome data for included studies were entered into Review Manager version 4.2.3 entered into Review Manager version 4.2.3 for Windows. The application of quality for Windows. The application of quality criteria and the accuracy of outcome data criteria and the accuracy of outcome data were double-checked by a second reviewer. were double-checked by a second reviewer.
Study characteristics Study characteristics
An initial narrative synthesis was undertaken An initial narrative synthesis was undertaken to describe the scope (participants, settings, to describe the scope (participants, settings, intervention type, comparators, measures of intervention type, comparators, measures of effect), quality and outcomes of the studies. effect), quality and outcomes of the studies. Three main efficacy outcomes were consid-Three main efficacy outcomes were considered: one dichotomous outcome (retaining a ered: one dichotomous outcome (retaining a diagnosis of PTSD) and two continuous out-diagnosis of PTSD) and two continuous outcomes (assessor-rated and self-reported sever-comes (assessor-rated and self-reported severity of PTSD symptoms). Among the main ity of PTSD symptoms). Among the main outcomes, the primary outcome was clini-outcomes, the primary outcome was clinician-rated severity of PTSD symptoms, cian-rated severity of PTSD symptoms, although this was not present for all studies. although this was not present for all studies.
Quantitative data synthesis Quantitative data synthesis
Where possible, meta-analysis was used to Where possible, meta-analysis was used to synthesise data, including additional meta-synthesise data, including additional metaanalyses for anxiety and depression mea-analyses for anxiety and depression measures where available, and numbers leaving sures where available, and numbers leaving the study early, using Review Manager. the study early, using Review Manager. Post-treatment data (or change scores if Post-treatment data (or change scores if reported instead of post-treatment data) reported instead of post-treatment data) for the psychological treatment and control for the psychological treatment and control condition were entered in the Review condition were entered in the Review Manager tables. Dichotomous outcomes Manager tables. Dichotomous outcomes (PTSD diagnosis and leaving the study early (PTSD diagnosis and leaving the study early for any reason) were analysed as a relative for any reason) were analysed as a relative risk number and were calculated on an risk number and were calculated on an intention-to-treat basis (i.e. a 'once ran-intention-to-treat basis (i.e. a 'once randomised always analyse' basis). This makes domised always analyse' basis). This makes the conservative assumption that all partici-the conservative assumption that all participants who ceased to engage in the study pants who ceased to engage in the study had an unfavourable outcome, e.g. they left had an unfavourable outcome, e.g. they left because the treatment was not acceptable because the treatment was not acceptable and still had a diagnosis of PTSD. Continu-and still had a diagnosis of PTSD. Continuous outcomes were analysed as standardised ous outcomes were analysed as standardised mean differences (SMDs) to allow for ease of mean differences (SMDs) to allow for ease of comparison across studies. It was not poss-comparison across studies. It was not possible to obtain intention-to-treat data for most ible to obtain intention-to-treat data for most of the trials, and we therefore used completer of the trials, and we therefore used completer data for all continuous outcomes. data for all continuous outcomes.
For consistency of presentation all data For consistency of presentation all data were entered into Review Manager in such were entered into Review Manager in such a way that negative effect sizes or relative risk a way that negative effect sizes or relative risk numbers less than 1 represented an effect that numbers less than 1 represented an effect that favoured the active treatment compared with favoured the active treatment compared with the waiting-list control. Data were pooled the waiting-list control. Data were pooled from more than one study using a fixed-from more than one study using a fixedeffects meta-analysis except where heteroge-effects meta-analysis except where heterogeneity was present, in which case a random-neity was present, in which case a randomeffects model was used as described below. effects model was used as described below.
Heterogeneity Heterogeneity
To check for heterogeneity between studies, To check for heterogeneity between studies, both the both the I I 2 2 -test of heterogeneity and the -test of heterogeneity and the w w 2 2 -test of heterogeneity ( test of heterogeneity (P P5 50.10) as well as 0.10) as well as visual inspection of the forest plots were used. visual inspection of the forest plots were used. The The I I 2 2 statistic describes the proportion of to-statistic describes the proportion of total variation in study estimates that is due to tal variation in study estimates that is due to heterogeneity (Higgins & Thompson, 2002) . heterogeneity (Higgins & Thompson, 2002) . An An I I 2 2 of less than 30% was taken to indicate of less than 30% was taken to indicate mild heterogeneity and a fixed-effects model mild heterogeneity and a fixed-effects model was used to synthesise the results. An was used to synthesise the results. An I I 2 2 of of more than 50% was taken as notable hetero-more than 50% was taken as notable heterogeneity; in this case an attempt was made to geneity; in this case an attempt was made to explain the variation. If studies with hetero-explain the variation. If studies with heterogeneous results were found to be comparable, geneous results were found to be comparable, a random-effects model was used to summar-a random-effects model was used to summarise the results (DerSimonian & Laird, 1986). ise the results (DerSimonian & Laird, 1986).
In the random-effects analysis, heterogeneity In the random-effects analysis, heterogeneity is accounted for both in the width of confi-is accounted for both in the width of confidence intervals and in the estimate of the dence intervals and in the estimate of the treatment effect. With decreasing heterogene-treatment effect. With decreasing heterogeneity the random-effects approach moves ity the random-effects approach moves asymptotically towards a fixed-effects model. asymptotically towards a fixed-effects model. An An I I 2 2 of 30-50% was taken to indicate mod-of 30-50% was taken to indicate moderate heterogeneity. In this case, both the erate heterogeneity. In this case, both the w w 2 2 -test of heterogeneity and a visual inspection test of heterogeneity and a visual inspection of the forest plot were used to decide between of the forest plot were used to decide between a fixed-and random-effects model. a fixed-and random-effects model.
In order to explore heterogeneity In order to explore heterogeneity further, sensitivity analyses were performed further, sensitivity analyses were performed to consider the influence of higher-quality to consider the influence of higher-quality methodology (this was done by considering methodology (this was done by considering studies that used masked assessment, and studies that used masked assessment, and those that used an intention-to-treat analy-those that used an intention-to-treat analysis), studies that only included females and sis), studies that only included females and those that only included Vietnam veterans. those that only included Vietnam veterans.
Clinical effectiveness Clinical effectiveness
Where psychological interventions were Where psychological interventions were compared against waiting-list control compared against waiting-list control groups an effect size (SMD) of groups an effect size (SMD) of 7 70.8 or less 0.8 or less (e.g. a larger negative number) was consid-(e.g. a larger negative number) was considered clinically meaningful for continuous ered clinically meaningful for continuous variables (a 'large' effect size; Cohen, variables (a 'large' effect size; Cohen, 1988) and for dichotomous outcomes a re-1988) and for dichotomous outcomes a relative risk of 0.65 or less (or greater than lative risk of 0.65 or less (or greater than 1.54) was considered clinically meaningful. 1.54) was considered clinically meaningful. Where two active treatments were com-Where two active treatments were compared lower thresholds were set with an pared lower thresholds were set with an SMD of SMD of 7 70.5 or +0.5 for continuous 0.5 or +0.5 for continuous variables (a 'medium' effect size), and for variables (a 'medium' effect size), and for dichotomous outcomes a relative risk of dichotomous outcomes a relative risk of 0.80 or less or 1.25 or greater was consid-0.80 or less or 1.25 or greater was considered clinically meaningful. These thresholds ered clinically meaningful. These thresholds came from discussions in the NICE Guide-came from discussions in the NICE Guideline Development Group in advance of line Development Group in advance of undertaking the meta-analyses and were undertaking the meta-analyses and were based on clinical experience and thresholds based on clinical experience and thresholds used in the literature used in the literature (Schnurr (Schnurr et al et al, 2003) . , 2003). In order to be considered clinically mean-In order to be considered clinically meaningful the value had to meet the threshold ingful the value had to meet the threshold criterion and the 95% confidence interval criterion and the 95% confidence interval had to be greater than the threshold. If had to be greater than the threshold. If the SMD and relative risk met the threshold the SMD and relative risk met the threshold criterion but the 95% CI included values in criterion but the 95% CI included values in the non-clinically significant range, this was the non-clinically significant range, this was interpreted as limited evidence for an effect. interpreted as limited evidence for an effect. Similarly, if the SMD or relative risk value Similarly, if the SMD or relative risk value was below the threshold, the 95% CIs were was below the threshold, the 95% CIs were examined to determine whether the evidence examined to determine whether the evidence was inconclusive (in case the 95% CI in-was inconclusive (in case the 95% CI included numbers greater than the threshold) cluded numbers greater than the threshold) or whether it could be stated that there was or whether it could be stated that there was evidence suggesting that an effect was evidence suggesting that an effect was unlikely (where the 95% CI was entirely unlikely (where the 95% CI was entirely outside the clinically meaningful range). outside the clinically meaningful range).
Psychological treatment categories Psychological treatment categories
Five separate psychological treatment cate-Five separate psychological treatment categories were defined (see Appendix). These gories were defined (see Appendix). These came from discussions by the NICE Guide 
RESULTS RESULTS
Thirty-eight studies were included in the Thirty-eight studies were included in the meta-analysis. Figure 1 shows the meta-meta-analysis. Figure 1 shows the metaanalysis profile summarising trial flow. analysis profile summarising trial flow. AUTHOR'S PROOF AUTHOR'S PROOF . These studies could not be ). These studies could not be included in the meta-analysis. included in the meta-analysis. Table 1 provides details of the quantitative Table 1 provides details of the quantitative data synthesis. It highlights that TFCBT data synthesis. It highlights that TFCBT and EMDR were better than waiting-list/ and EMDR were better than waiting-list/ control on most outcome measures. Stress control on most outcome measures. Stress management was better on some outcomes, management was better on some outcomes, and 'other therapies' appeared to be the and 'other therapies' appeared to be the least effective. Unfortunately none of the least effective. Unfortunately none of the studies reported adverse effects and studies reported adverse effects and therefore it was not possible to analyse therefore it was not possible to analyse these. However, most studies did report these. However, most studies did report withdrawal rates and these are included in withdrawal rates and these are included in Table 1 . Table 1 .
Study characteristics Study characteristics

Quantitative data synthesis Quantitative data synthesis
Sensitivity analyses Sensitivity analyses
Masked assessment Masked assessment
The EMDR studies using masked assess-The EMDR studies using masked assessment showed evidence favouring EMDR ment showed evidence favouring EMDR over waiting-list on reducing the severity over waiting-list on reducing the severity of PTSD symptoms (clinician-rated mea-of PTSD symptoms (clinician-rated measures) (three studies, sures) (three studies, n n¼120; SMD 120; SMD¼7 71.54, 1.54, 1.54, 95% CI 1.54, 95% CI 7 71.95 to 1.95 to 7 71.12) similar to 1.12) similar to that in all EMDR studies (see Table 1 ). that in all EMDR studies (see Table 1 ). The TFCBT studies using masked assess-The TFCBT studies using masked assessment showed evidence favouring TFCBT ment showed evidence favouring TFCBT over waiting-list on reducing the over waiting-list on reducing the severity of severity of PTSD symptoms (clinician-PTSD symptoms (clinician-rated measures) rated measures) (seven studies, (seven studies, n n¼308; SMD 308; SMD¼7 71.70; 95% 1.70; 95% CI CI 7 72.47 to 2.47 to 7 70.93) similar to that in all 0.93) similar to that in all TFCBT studies. TFCBT studies.
Vietnam veteran studies Vietnam veteran studies
One EMDR study considered only Vietnam One EMDR study considered only Vietnam veterans. This showed less evidence veterans. This showed less evidence favouring EMDR over waiting-list on favouring EMDR over waiting-list on reducing the severity of PTSD symptoms reducing the severity of PTSD symptoms (clinician-rated measures) (one study, (clinician-rated measures) (one study, n n¼25; SMD 25; SMD¼7 70.97, 95% CI 0.97, 95% CI 7 71.81 to 1.81 to 7 70.13) than the other EMDR studies (see 0.13) than the other EMDR studies (see Table 1 ). One TFCBT study considered Table 1 ). One TFCBT study considered only Vietnam veterans using the primary only Vietnam veterans using the primary outcome measure; this showed less evidence outcome measure; this showed less evidence favouring TFCBT over waiting-list on redu-favouring TFCBT over waiting-list on reducing the severity of PTSD symptoms (clini-cing the severity of PTSD symptoms (clinician-rated measures) (one study, cian-rated measures) (one study, n n¼24; 24; SMD SMD¼7 70.22, 95% CI 0.22, 95% CI 7 71.03 to 0.58) 1.03 to 0.58) than the other TFCBT studies. than the other TFCBT studies.
Female studies Female studies
The EMDR studies including only female The EMDR studies including only female participants showed evidence favouring participants showed evidence favouring EMDR over waiting-list on reducing the EMDR over waiting-list on reducing the severity of PTSD symptoms (clinician-rated severity of PTSD symptoms (clinician-rated measures) (two studies, measures) (two studies, n n¼57; SMD 57; SMD¼ 7 71.67, 95% CI 1.67, 95% CI 7 72.30 to 2.30 to 7 71.04) similar 1.04) similar to that in all EMDR studies. The TFCBT to that in all EMDR studies. The TFCBT studies including only female participants studies including only female participants showed more evidence favouring TFCBT showed more evidence favouring TFCBT over waiting-list on reducing the severity over waiting-list on reducing the severity of PTSD symptoms (clinician-rated mea-of PTSD symptoms (clinician-rated measures) (six studies, sures) (six studies, n n¼358; SMD 358; SMD¼7 72.06, 2.06, 95% CI 95% CI 7 72.70 to 2.70 to 7 71.42) than all TFCBT 1.42) than all TFCBT studies. studies.
Intention-to-treat analysis Intention-to-treat analysis
None of the EMDR studies reported using None of the EMDR studies reported using an intention-to-treat analysis so this could an intention-to-treat analysis so this could not be assessed. The TFCBT studies using not be assessed. The TFCBT studies using an intention-to-treat analysis showed more an intention-to-treat analysis showed more evidence favouring TFCBT over waiting-list evidence favouring TFCBT over waiting-list on reducing the severity of PTSD symptoms on reducing the severity of PTSD symptoms (clinician-rated measures) (six studies, (clinician-rated measures) (six studies, n n¼332; SMD 332; SMD¼7 71.82, 95% CI 1.82, 95% CI 7 72.76 to 2.76 to 7 70.89) than all TFCBT studies. 0.89) than all TFCBT studies.
DISCUSSION DISCUSSION
We identified 38 randomised controlled We identified 38 randomised controlled trials of psychological treatments for PTSD. trials of psychological treatments for PTSD. Trauma-focused cognitive-behavioural Trauma-focused cognitive-behavioural therapy showed clinically important bene-therapy showed clinically important benefits over waiting-list or usual care on all fits over waiting-list or usual care on all measures of PTSD symptoms. In addition, measures of PTSD symptoms. In addition, there was limited evidence that it also has there was limited evidence that it also has clinically important effects on depression clinically important effects on depression and anxiety. The effectiveness of eye move-and anxiety. The effectiveness of eye movement desensitisation and reprocessing ment desensitisation and reprocessing was also generally supported by the meta-was also generally supported by the metaanalysis, but the evidence base was not as analysis, but the evidence base was not as strong as that for TFCBT, both in terms strong as that for TFCBT, both in terms of the number of trials available and the of the number of trials available and the certainty with which clinical benefit was es-certainty with which clinical benefit was established. Furthermore, there was limited tablished. Furthermore, there was limited evidence that TFCBT and EMDR were evidence that TFCBT and EMDR were superior to supportive/non-directive treat-superior to supportive/non-directive treatments, hence it is highly unlikely that their ments, hence it is highly unlikely that their effectiveness is due to non-specific factors effectiveness is due to non-specific factors such as attention. There was limited evi-such as attention. There was limited evidence for dence for stress management and group stress management and group cognitive-cognitive-behavioural therapy, but 'other behavioural therapy, but 'other therapy' (supportive/non-directive therapy, therapy' (supportive/non-directive therapy, psychodynamic therapies and hypno-psychodynamic therapies and hypnotherapies) that focused on current or past therapies) that focused on current or past aspects of the patient's life other than the aspects of the patient's life other than the trauma or on general support did not show trauma or on general support did not show clinically important effects on PTSD symp-clinically important effects on PTSD symptoms, depression or anxiety. However, this toms, depression or anxiety. However, this might be due to the limited number of might be due to the limited number of studies available and does not mean studies available and does not mean that these treatments were shown to be that these treatments were shown to be ineffective. ineffective.
The treatments most supported by the The treatments most supported by the review (individually delivered TFCBT and review (individually delivered TFCBT and EMDR) are both trauma-focused psycho-EMDR) are both trauma-focused psychological treatments that specifically address logical treatments that specifically address the patient's troubling memories of the the patient's troubling memories of the traumatic event and the personal meanings traumatic event and the personal meanings of the event and its consequences. Direct of the event and its consequences. Direct comparisons of these two approaches did comparisons of these two approaches did not reveal any significant advantages of not reveal any significant advantages of 
Heterogeneity Heterogeneity
There is clearly considerable clinical There is clearly considerable clinical diversity within the studies considered. diversity within the studies considered. The separation of different active inter-The separation of different active interventions into groups partially addresses ventions into groups partially addresses their impact on clinical diversity, but not their impact on clinical diversity, but not all trials within the same group used identi-all trials within the same group used identical interventions. The differences were cal interventions. The differences were most marked in the 'other therapy' group, most marked in the 'other therapy' group, which had in common the absence of which had in common the absence of cognitive-behavioural techniques and cognitive-behavioural techniques and trauma-focused work. There was also trauma-focused work. There was also diversity in the TFCBT group, which diversity in the TFCBT group, which included both exposure-only and trauma-included both exposure-only and traumafocused cognitive therapy interventions. focused cognitive therapy interventions.
Another source of heterogeneity was Another source of heterogeneity was the quality of the studies. Sensitivity the quality of the studies. Sensitivity analyses of higher-quality and lower-analyses of higher-quality and lowerquality studies were performed to explore quality studies were performed to explore this further. There was some limited this further. There was some limited evidence that higher-quality studies (those evidence that higher-quality studies (those including masked assessment of outcome including masked assessment of outcome or intention-to-treat analysis) showed or intention-to-treat analysis) showed better outcomes than the lower-quality better outcomes than the lower-quality studies. This finding contradicts previous studies. This finding contradicts previous research research (Moher (Moher et al et al, 1998) that has found , 1998) that has found an association between poorer method-an association between poorer methodology and more favourable results for the ology and more favourable results for the intervention. It may reflect the fact that intervention. It may reflect the fact that the better studies tended to be more recent the better studies tended to be more recent and associated with refinement of techni-and associated with refinement of techniques. They also included most of the ques. They also included most of the female-only studies. The fact that female-female-only studies. The fact that femaleonly studies showed a better response to only studies showed a better response to TFCBT than mixed studies and male-only TFCBT than mixed studies and male-only studies is difficult to interpret. It may be studies is difficult to interpret. It may be that the female-only studies used more that the female-only studies used more effective interventions, that the trauma of effective interventions, that the trauma of rape is more amenable than other traumas rape is more amenable than other traumas to effective TFCBT, or that for some unde-to effective TFCBT, or that for some undetermined reason women are more respon-termined reason women are more responsive to TFCBT than men. Interestingly, a sive to TFCBT than men. Interestingly, a similar superiority in female response has similar superiority in female response has been found for pharmacological treatment been found for pharmacological treatment of PTSD of PTSD ( As with all psychological treatment As with all psychological treatment trials, there are issues with the control trials, there are issues with the control group. The development of a psychological group. The development of a psychological treatment placebo is difficult, if not imposs-treatment placebo is difficult, if not impossible, as is masking of participants and ible, as is masking of participants and therapists. In several of the waiting-list or therapists. In several of the waiting-list or usual care conditions it was apparent that usual care conditions it was apparent that some (usually poorly defined) treatment some (usually poorly defined) treatment was going on. The main effect of this is was going on. The main effect of this is likely to have made it more difficult for likely to have made it more difficult for the active intervention to show itself to be the active intervention to show itself to be superior to the control condition. superior to the control condition.
Tolerability Tolerability
Unfortunately none of the studies reported Unfortunately none of the studies reported adverse effects. It remains unclear whether adverse effects. It remains unclear whether no adverse effects occurred, or whether no adverse effects occurred, or whether they were not described. This is a key short-they were not described. This is a key shortcoming in the trials identified. Most studies coming in the trials identified. Most studies reported withdrawals by group. There are reported withdrawals by group. There are likely to be several different factors that likely to be several different factors that determine withdrawal rates, including the determine withdrawal rates, including the tolerability of the intervention. There was tolerability of the intervention. There was limited evidence that TFCBT and other limited evidence that TFCBT and other therapies fared worse than waiting-list or therapies fared worse than waiting-list or usual care on this outcome measure, but usual care on this outcome measure, but there was no significant difference in with-there was no significant difference in withdrawal rates in direct comparisons between drawal rates in direct comparisons between any of the active treatments. The higher-any of the active treatments. The higherquality TFCBT studies showed no differ-quality TFCBT studies showed no difference in withdrawal rates when compared ence in withdrawal rates when compared with waiting-list or usual care. Some people with waiting-list or usual care. Some people find it difficult to fully engage in psycho-find it difficult to fully engage in psychological treatment because it requires a logical treatment because it requires a significant commitment of time and emo-significant commitment of time and emotion. For some people with PTSD it may tion. For some people with PTSD it may initially be difficult and overwhelming to initially be difficult and overwhelming to disclose details of their traumatic events. disclose details of their traumatic events. It is also well recognised that some patients It is also well recognised that some patients may be subject to initial adverse effects may be subject to initial adverse effects such as increased re-experiencing following such as increased re-experiencing following exposure treatment exposure treatment (Pitman . Withdrawal rates of up to 30% in some studies drawal rates of up to 30% in some studies suggest that the active treatments were not suggest that the active treatments were not always acceptable to those receiving them. always acceptable to those receiving them. It is possible that in these cases devoting It is possible that in these cases devoting several sessions to establishing a trusting several sessions to establishing a trusting therapeutic relationship and emotional sta-therapeutic relationship and emotional stabilisation, before addressing the traumatic bilisation, before addressing the traumatic event, might lead to greater acceptability. event, might lead to greater acceptability.
Limitations of the meta-analysis Limitations of the meta-analysis
Although this meta-analysis provides a Although this meta-analysis provides a systematic and comprehensive comparison systematic and comprehensive comparison of the different psychological treatments of the different psychological treatments of PTSD, it is not without methodological of PTSD, it is not without methodological problems. The randomised controlled trials problems. The randomised controlled trials analysed usually reported unadjusted analysed usually reported unadjusted means for the treatment conditions after means for the treatment conditions after therapy and at follow-up therapy and at follow-up. Sample sizes . Sample sizes were usually small, raising the chance that were usually small, raising the chance that baseline differences present before treat-baseline differences present before treatment influenced scores after treatment. ment influenced scores after treatment. Indeed, some studies showed baseline Indeed, some studies showed baseline differences between the study conditions differences between the study conditions that remained uncorrected in our analysis. that remained uncorrected in our analysis. However, across studies no systematic However, across studies no systematic baseline difference existed, so the conclu-baseline difference existed, so the conclusions remain valid. Furthermore, the Re-sions remain valid. Furthermore, the Review Manager program does not allow view Manager program does not allow entering a score of 0 for both groups. Thus, entering a score of 0 for both groups. Thus, the withdrawal rates reported are slight the withdrawal rates reported are slight overestimates of the true rates. overestimates of the true rates.
Clinical implications Clinical implications
Our results suggest that trauma-focused Our results suggest that trauma-focused psychological treatments (TFCBT or psychological treatments (TFCBT or EMDR) are effective for chronic PTSD. EMDR) are effective for chronic PTSD. Indeed, the effect sizes compare favourably Indeed, the effect sizes compare favourably with those found for cognitive-behavioural with those found for cognitive-behavioural therapy in depressive and anxiety disorders therapy in depressive and anxiety disorders The results also suggest that not all chronic PTSD will also suggest that not all chronic PTSD will benefit from these treatments; other benefit from these treatments; other approaches should then be considered, approaches should then be considered, including extending the number of sessions, including extending the number of sessions, trying an alternative form of trauma-trying an alternative form of trauma- 
Future research Future research
Further well-designed trials of psycho-Further well-designed trials of psychological treatments are required, including logical treatments are required, including further comparison studies of one type of further comparison studies of one type of psychological treatment against another. psychological treatment against another. There is a need for large-scale studies There is a need for large-scale studies (phase 4) to find out whether the results (phase 4) to find out whether the results will survive in real practice. Future trials will survive in real practice. Future trials should consider adverse events and toler-should consider adverse events and tolerability of treatment in more detail. Our re-ability of treatment in more detail. Our results suggest that several of the currently sults suggest that several of the currently available treatments might benefit from available treatments might benefit from modifications that would make them more modifications that would make them more acceptable to people with chronic PTSD acceptable to people with chronic PTSD and possibly also more effective. There is and possibly also more effective. There is also potential for research concerning the also potential for research concerning the direct comparison of psychological treat-direct comparison of psychological treatments with pharmacological treatments, ments with pharmacological treatments, the effectiveness of a combination of the the effectiveness of a combination of the two, and the implications of the high degree two, and the implications of the high degree of comorbidity with other disorders for the of comorbidity with other disorders for the choice of treatment. choice of treatment.
APPENDIX APPENDIX
Psychological treatment categories Psychological treatment categories
Treatments delivered on an individual basis Treatments delivered on an individual basis that focused on the memory for the traumatic that focused on the memory for the traumatic event and its meaning event and its meaning 
